Overview of CJC-1295 DAC for Research
CJC-1295 DAC is a synthetic analog of growth hormone-releasing hormone (GHRH) that incorporates a drug affinity complex (DAC) moiety. In research models, this modification allows the peptide to bind reversibly to serum albumin, substantially prolonging its presence in biological matrices. Laboratory investigations employ CJC-1295 DAC to examine growth hormone secretion kinetics, somatotroph responsiveness, and downstream anabolic signaling pathways. All handling and application of this peptide are strictly confined to in vitro assays and approved animal research protocols; it is not manufactured for, nor may it be used in, human or veterinary contexts.
Chemical Structure and Purity Standards
The DAC component is a maleimide-functionalized group that selectively conjugates to the free thiol of circulating albumin after administration in research animals. This covalent attachment shields the peptide from rapid renal clearance and enzymatic proteolysis, yielding an extended observable half-life compared to unmodified GHRH analogs. For reliable and reproducible experimental outcomes, research-grade CJC-1295 DAC must meet stringent purity thresholds. High-performance liquid chromatography (HPLC) is the benchmark method, with an acceptance criterion typically set at ≥99% chromatographic purity. Complementary techniques such as mass spectrometry (MS) confirm the exact molecular weight, while amino acid analysis verifies primary sequence integrity. Comprehensive impurity profiling—including quantification of residual organic solvents, counterions like acetate or trifluoroacetate, and unreacted truncation products—is essential to ensure batch-to-batch consistency and minimize confounding variables in biological assays.
- HPLC-Reinheit: ≥99% at 214 nm, using a validated gradient method, is standard for reliable research.
- Mass confirmation: Electrospray ionization (ESI) or matrix-assisted laser desorption/ionization (MALDI) MS should match the theoretical monoisotopic mass within ±1 Da.
- Counterion content: Determination of trifluoroacetate (TFA) and acetate levels by ion chromatography or HPLC helps correct for net peptide content.
- Residual solvents: Gas chromatography quantifies manufacturing solvents (e.g., acetonitrile, dichloromethane) to verify they fall below ICH Q3C guideline limits for research materials.
The Importance of Certificate of Analysis (COA)
When sourcing CJC-1295 DAC from a supplier with COA, researchers receive a formal document that certifies the analytical results for a specific production batch. This document transforms a commercial peptide into a well-characterized research reagent. The COA is indispensable for data integrity, enabling laboratories to trace any experimental anomaly back to the exact material used. It serves as objective evidence of identity, purity, and composition, which is particularly critical when results are published or submitted to regulatory reviewers in preclinical contexts. Without a proper COA, the validity of an entire experimental dataset can be questioned, as unverified peptide content or the presence of bioactive impurities could lead to misinterpretation of dose-response relationships or off-target effects.
What a COA Typically Includes
A thorough COA from a specialized peptide supplier goes beyond a mere purity statement. It disaggregates several quality attributes that collectively define the batch. These data points are generated using orthogonal analytical methodologies, as no single technique can capture all relevant characteristics. The following elements are commonly reported:
- Peptide identification: Sequence confirmation via tandem MS/MS fragmentation spectra, and often an HPLC chromatogram overlay with a reference standard, demonstrating retention time consistency.
- Net peptide content: Measured by quantitative amino acid analysis or nitrogen determination, accounting for counterions and water. This value corrects the gravimetric mass, so that the effective peptide amount in solution is known.
- Water content: Karl Fischer titration quantifies residual moisture in the lyophilized powder, which influences stability and weighing accuracy.
- TFA content: When applicable, the percentage of residual trifluoroacetic acid (often from HPLC purification) is reported; levels below 1% are commonly sought for sensitive cell-based assays.
- Solubility and appearance: A visual inspection note (e.g., white to off-white lyophilized cake) and, in some cases, a recommended reconstitution solvent.
- Lot-specific traceability: Unique lot number, manufacturing date, retest/re-test date, storage conditions, and the signature or electronic approval of quality assurance personnel.
Selecting a Reliable CJC-1295 DAC Supplier with COA
The decision to partner with a particular CJC-1295 DAC supplier goes beyond catalog pricing and delivery speed. For laboratories conducting mechanistic studies or preclinical evaluations, the supplier’s commitment to analytical transparency is paramount. A supplier that routinely provides a detailed COA and a safety data sheet (SDS) with every shipment demonstrates a quality-centric culture. It also allows researchers to audit the documentation before committing material to costly and time-consuming experiments. Evaluating a supplier’s full quality system, rather than a single data point, helps mitigate the risk of receiving substandard or misidentified peptide batches.
Key Criteria for Supplier Evaluation
When vetting potential suppliers for research-grade CJC-1295 DAC, consider the following interconnected factors:
- Synthesis and purification expertise: Look for manufacturers with a demonstrated history in solid-phase peptide synthesis (SPPS) and preparative HPLC. In-house capability for orthogonal purification steps (e.g., ion exchange) and lyophilization ensures tighter control over the final product profile. Suppliers should be able to describe their typical process without revealing proprietary details, confirming good manufacturing practice (GMP)-like principles suitable for research chemicals.
- Analytical capabilities and third-party verification: A robust supplier performs all major analytical tests internally (HPLC, MS, Karl Fischer) and may also submit batches to independent, accredited laboratories for confirmatory testing. Affiliations with ISO 9001 certified quality management systems or adherence to the principles of ICH Q7 (even for non-pharmaceutical material) indicate a mature quality framework.
- Batch-specific documentation accessibility: The ease with which a researcher can obtain a COA for a given lot—either by downloading it from a website portal before purchase or by receiving it printed with the shipment—reflects the supplier’s commitment to transparency. Some suppliers provide a full analytical data package, including raw chromatograms and spectra, which is invaluable for in-house quality assurance checks.
- Packaging and logistics: CJC-1295 DAC is typically shipped as a lyophilized powder in inert gas-flushed, sealed glass vials to protect against moisture and oxidation. For long-haul transport during warm seasons, an insulated container with cooling packs may be offered if stability data indicate a sensitivity to high temperature. Clear labeling with lot number, storage condition (-20°C recommended for long term), and the research-use-only disclaimer is essential for customs clearance and proper laboratory reception.
- Customer support and regulatory knowledge: Responsive technical teams that can explain analytical variations (e.g., a minor pre-peak in HPLC from a specific conformer) and provide batch-specific re-issue COAs instills confidence. Furthermore, a supplier experienced in international research chemical logistics can guide institutions through documentation requirements, such as end-user declarations, avoiding customs delays.
- Reputation and longevity: A supplier that has consistently served research institutions, contract research organizations, and pharmaceutical companies over several years is more likely to have established rigorous quality protocols. Independent researcher forums and peer publications often cite or discuss supplier performance, offering informal but useful long-term evidence of reliability.
Compliance- und regulatorische Aspekte
Procurement and use of CJC-1295 DAC are governed by a clear framework: the peptide is strictly a laboratory research reagent, not a pharmaceutical ingredient or a dietary component. In many jurisdictions, research peptides fall under general chemical regulations unless explicitly controlled. However, several countries have introduced specific import controls for peptide analogs with potential biological activity. Buyers bear the responsibility to confirm that their intended research is lawful in the destination country and that all necessary permits, import licenses, or end-user statements have been obtained. Suppliers must support this by ensuring all outward packaging and accompanying documentation clearly state “For Laboratory Research Use Only – Not for Human or Veterinary Use” and refrain from any implication of suitability for therapeutic application.
Additionally, some regulatory authorities require a detailed end-user declaration that identifies the purchasing principal investigator, the institution, and a brief description of the research purpose. When such a declaration is needed, a competent supplier will proactively request and verify the completed form before shipping. Internal quality systems of the supplier should also systematically re-evaluate purity profiles and storage conditions against published stability data, so that any lot approaching its retest date is retested and its COA updated accordingly. This closed-loop quality process supports the overarching compliance requirement: the generation of precise, verifiable research data.
Nur für Forschungszwecke
All information provided herein refers exclusively to the chemical compound CJC-1295 DAC as a research tool. This product is intended solely for in vitro laboratory and non-human animal research purposes, in accordance with applicable laws and institutional guidelines. It is not designed, manufactured, or approved for human or veterinary clinical use, nor for the diagnosis, mitigation, or prevention of any disease. Any mention of biological mechanisms or analytical methods is for informational context and does not suggest suitability for administration in a clinical setting.
Nur für Forschungszwecke. Nicht zur Anwendung am Menschen oder bei Tieren bestimmt.
